Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeane Silva

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Cancer Research|March 25, 2014
Sepantronium is a DNA damaging agent that synergizes with PLK1 inhibitor volasertibMei Hong, Mingqiang Ren, Jeane Silva, et al.
Journal of Telemedicine and Telecare|August 24, 2023
Design and development of a Telemedicine Assessment Toolkit (TAT) for the assessment of audiovisual telemedicine encountersRaphael Agbali, E Andrew Balas, Vahe Heboyan, et al.
Oncology Reports|April 9, 2013
Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1Mingqiang Ren, Mei Hong, Gentao Liu, et al.
Biochemistry|September 18, 2002
Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferasesErhard Bieberich, Sarah MacKinnon, Jeane Silva, et al.
Journal of Ethnopharmacology|November 13, 2003
Analgesic and anti-inflammatory effects of essential oils of EucalyptusJeane Silva, Worku Abebe, S M Sousa, et al.
Genomics|November 16, 2018
Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndromeJeane Silva, Chang-Sheng Chang, Tianxiang Hu, et al.
Oncogene|January 26, 2018
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinaseTianxiang Hu, Yating Chong, Haiyan Qin, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2026
Evaluation of chimerism testing by next generation sequencing using indel markers: Analytical validation and examples of clinical utilizationShannon Dutterer, Christle Moore, Maya Giddens, et al.
Cancer Letters|November 15, 2002
Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cellsErhard Bieberich, Bin Hu, Jeane Silva, et al.
Anti-Cancer Drugs|October 19, 2016
YM155 inhibits topoisomerase functionMei Hong, Ming-Qiang Ren, Jeane Silva, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Cancer Research|March 25, 2014
Sepantronium is a DNA damaging agent that synergizes with PLK1 inhibitor volasertibMei Hong, Mingqiang Ren, Jeane Silva, et al.
Journal of Telemedicine and Telecare|August 24, 2023
Design and development of a Telemedicine Assessment Toolkit (TAT) for the assessment of audiovisual telemedicine encountersRaphael Agbali, E Andrew Balas, Vahe Heboyan, et al.
Oncology Reports|April 9, 2013
Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1Mingqiang Ren, Mei Hong, Gentao Liu, et al.
Biochemistry|September 18, 2002
Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferasesErhard Bieberich, Sarah MacKinnon, Jeane Silva, et al.
Journal of Ethnopharmacology|November 13, 2003
Analgesic and anti-inflammatory effects of essential oils of EucalyptusJeane Silva, Worku Abebe, S M Sousa, et al.
Genomics|November 16, 2018
Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndromeJeane Silva, Chang-Sheng Chang, Tianxiang Hu, et al.
Oncogene|January 26, 2018
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinaseTianxiang Hu, Yating Chong, Haiyan Qin, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2026
Evaluation of chimerism testing by next generation sequencing using indel markers: Analytical validation and examples of clinical utilizationShannon Dutterer, Christle Moore, Maya Giddens, et al.
Cancer Letters|November 15, 2002
Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cellsErhard Bieberich, Bin Hu, Jeane Silva, et al.
Anti-Cancer Drugs|October 19, 2016
YM155 inhibits topoisomerase functionMei Hong, Ming-Qiang Ren, Jeane Silva, et al.
Pageof 4